skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: Cambridge coronavirus vaccine enters clinical trial: Needle-free vaccine targets COVID-19 variants and future coronaviruses

Cambridge coronavirus vaccine enters clinical trial: Needle-free vaccine targets COVID-19 variants and future coronaviruses

16 December 2021

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility. Developed by Professor Jonathan...

Read more

Read more at: Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

8 November 2021

An international study of more than 50,000 people with irritable bowel syndrome (IBS) has revealed that IBS symptoms may be caused by the same biological processes as conditions such as anxiety. The research highlights the close relationship between brain and gut health and paves the way for development of new treatments...

Read more

Read more at: Whole genome sequencing increases diagnosis of rare disorders by nearly a third

Whole genome sequencing increases diagnosis of rare disorders by nearly a third

8 November 2021

Whole genome sequencing from a single blood test picks up 31% more cases of rare genetic disorders than standard tests, shortening the ‘diagnostic odyssey’ that affected families experience, and providing huge opportunities for future research. A definitive genetic diagnosis can really help patients and their families...

Read more

Read more at: Gut bacteria accumulate many common medications and may reduce their effectiveness

Gut bacteria accumulate many common medications and may reduce their effectiveness

14 September 2021

Common medications can accumulate in gut bacteria, a new study has found, altering bacterial function and potentially reducing the medications’ effectiveness. If we can characterise how people respond depending on the composition of their microbiome, then drug treatments could be individualised Kiran Patil These...

Read more

Read more at: Biological ‘fingerprints’ of long COVID in blood could lead to diagnostic test, say Cambridge scientists

Biological ‘fingerprints’ of long COVID in blood could lead to diagnostic test, say Cambridge scientists

20 July 2021

Markers in our blood – ‘fingerprints’ of infection – could help identify individuals who have been infected by SARS-CoV-2, the coronavirus that causes COVID-19, several months after infection even if the individual had only mild symptoms or showed no symptoms at all, say Cambridge researchers. Because we currently have no...

Read more

Read more at: Apollo Therapeutics launches with £100m investment

Apollo Therapeutics launches with £100m investment

21 June 2021

Pioneering collaboration initiated by the University of Cambridge, Imperial College London and University College London A pioneering collaboration to speed development of breakthrough medical discoveries—devised by the University of Cambridge, Imperial College London, University College London and embraced by...

Read more

Read more at: Switching off heart protein could protect against heart failure

Switching off heart protein could protect against heart failure

27 May 2021

Switching off a heart muscle protein could provide a new way for drugs to combat heart failure in people who’ve had a heart attack, according to research led by the University of Cambridge and published in the journal Nature . After years of research we’ve revealed an entirely new and promising way that could help the...

Read more

Read more at: Scientists develop new class of cancer drug with potential to treat leukaemia

Scientists develop new class of cancer drug with potential to treat leukaemia

27 April 2021

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature , Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could...

Read more

Read more at: €2m boost for gene and cell therapy info hub

€2m boost for gene and cell therapy info hub

15 April 2021

A new EU-funded project is set to provide accessible and reliable information about cell and gene-based therapies. The € 2m initiative will develop an online hub to provide accurate information on the use of cells and genetic material to treat disease, along with evidence-based information to counter misinformation...

Read more

Read more at: Researchers call for greater awareness of unintended consequences of CRISPR gene editing

Researchers call for greater awareness of unintended consequences of CRISPR gene editing

15 April 2021

CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA in early human embryos, researchers have revealed. This highlights the need for further research into the effects of CRISPR-Cas9 genome editing, especially when used to edit human DNA in laboratory research. We and others are trying...

Read more